UPDATED 20.02.2014 10:52

Organised cervical cancer screening programme in the Helsinki and Uusimaa health care district in Finland in the invitation year 2004. Numbers and percentage distribution of primary screening test results, referrals for further examinations, and histological diagnosis of the cervix uteri.

Screening Screened Referral Histological diagnosis
test     Invasive
carcinoma
Microinvasive
carcinoma
Carcinoma
in situ
Dysplasia
gravis
Dysplasia
moderata
Dysplasia
levis
Other or
normal
  n n % n % n % n % n % n % n % n %
Pap test1 19940 267 1.34 2 0.01 2 0.01 1 0.01 14 0.07 55 0.28 19 0.10 174 0.87
I 17984 - - - - - - - - - - - - - - - -
II 1688 47 0.24 1 0.01 - - 1 0.01 1 0.01 3 0.02 1 0.01 40 0.20
III 205 205 1.03 1 0.01 - - - - 10 0.05 48 0.24 15 0.08 131 0.66
IV 15 15 0.08 - - 2 0.01 - - 3 0.02 4 0.02 3 0.02 3 0.02
V - - - - - - - - - - - - - - - - -
Inadequate 48 - - - - - - - - - - - - - - - -
Unknown - - - - - - - - - - - - - - - - -
HPV test 7542 107 1.42 2 0.03 - - - - 4 0.05 34 0.45 10 0.13 57 0.76
Negative1 6881 3 0.04 - - - - - - - - - - - - 3 0.04
Positive2 661 104 1.38 2 0.03 - - - - 4 0.05 34 0.45 10 0.13 54 0.72
Total 27482 374 1.36 4 0.01 2 0.01 1 0.00 18 0.07 89 0.32 29 0.11 231 0.84

1 Women with Papanicolaou class I or II negative HPV test are not referred for further examinations unless repeated cytology or other results are suggestive of cancer.
2 Women whose HPV test is positive are referred for further examinations on the basis of cytology or a repeatedly positive result.